Association between fibrinogen level and length of stay in patients with lower extremity atherosclerotic disease: a retrospective cohort study.

ABSTRACT: The level of fibrinogen in patients with lower extremity atherosclerosis (LEAD) has been widely identified as a risk factor contributing to adverse outcomes. However, some knowledge gaps remain regarding fibrinogen levels and downstream adverse outcomes, such as length of stay (LOS). We conducted this study to examine the association between fibrinogen level and LOS in LEAD patients. The retrospective cohort study included 1428 LEAD patients between January 2014 and November 2021 in China. Several generalized linear models with a negative binomial link function were used to evaluate the association between fibrinogen level and LOS. The area under the curve (AUC) was used to evaluate the predicting effect of fibrinogen level on a LOS greater than 10 days (median LOS). The median age of the

SUBMITTER: Wang X 

PROVIDER: S-EPMC10363167 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature